Symbols / IMNM Stock $23.78 -0.29% Immunome, Inc.

Healthcare • Biotechnology • United States • NCM
IMNM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Stock Fundamentals
Scroll to Statements
Market Cap 2.69B Enterprise Value 2.04B Income -212.39M Sales 6.94M Book/sh 5.61 Cash/sh 5.78
Dividend Yield — Payout 0.00% Employees 177 IPO — P/E — Forward P/E -11.25
PEG — P/S 387.60 P/B 4.24 P/C — EV/EBITDA -9.64 EV/Sales 294.00
Quick Ratio 14.53 Current Ratio 14.69 Debt/Eq 0.61 LT Debt/Eq — EPS (ttm) -2.43 EPS next Y -2.11
EPS Growth — Revenue Growth -100.00% Earnings 2026-05-12 ROA -28.98% ROE -52.09% ROIC —
Gross Margin 0.00% Oper. Margin -30.85% Profit Margin 0.00% Shs Outstand 113.13M Shs Float 94.31M Short Float 17.31%
Short Ratio 12.26 Short Interest — 52W High 27.65 52W Low 7.15 Beta 2.14 Avg Volume 1.26M
Volume 632.40K Target Price $35.54 Recom Strong_buy Prev Close $23.85 Price $23.78 Change -0.29%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$35.54
Mean price target
2. Current target
$23.78
Latest analyst target
3. DCF / Fair value
$-21.26
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$23.78
Low
$30.00
High
$40.00
Mean
$35.54

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-04 main Craig-Hallum Buy → Buy $36
2026-03-04 main Stephens & Co. Overweight → Overweight $30
2026-02-12 init HC Wainwright & Co. — → Buy $40
2026-01-15 reit Wedbush Outperform → Outperform $31
2025-12-16 main Lake Street Buy → Buy $32
2025-12-16 main Evercore ISI Group Outperform → Outperform $40
2025-12-16 main Guggenheim Buy → Buy $35
2025-12-01 init Truist Securities — → Buy $36
2025-11-17 main Stephens & Co. Overweight → Overweight $33
2025-09-22 init Goldman Sachs — → Buy $26
2025-09-05 init Craig-Hallum — → Buy $26
2025-08-25 reit Guggenheim Buy → Buy $25
2025-08-22 init Evercore ISI Group — → Outperform $18
2025-08-07 main JP Morgan Overweight → Overweight $22
2025-04-02 init Lake Street — → Buy $23
2025-03-20 reit Wedbush Outperform → Outperform $33
2025-03-20 reit Stephens & Co. Overweight → Overweight $30
2025-03-20 main Guggenheim Buy → Buy $25
2025-03-11 init LifeSci Capital — → Outperform $20
2024-11-14 main Piper Sandler Overweight → Overweight $21
News
RSS: Latest IMNM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-02 ROSETT MAX Chief Financial Officer — 65,000 $21.91 $1,424,916
2026-04-02 ROSETT MAX Chief Financial Officer — 71,561 $1.05 $87,053
2026-04-02 HIGGINS JACK Officer — 9,438 $21.64 $204,238
2026-03-30 HIGGINS JACK Officer — 6,291 $0.00 $0
2026-03-27 SIEGALL CLAY B Chief Executive Officer — 25,450 $19.67 $500,602
2026-03-23 WAGENHEIM PHILIP R Director — 65,000 $20.47 $1,335,626
2026-03-11 BIENAIME JEAN-JACQUES Director — 2,000 $21.55 $43,670
2025-12-30 SIEGALL CLAY B Chief Executive Officer — 4,729 $21.15 $100,018
2025-12-22 BARCHAS ISAAC Director — 383,200 $21.72 $8,330,080
2025-12-19 SIEGALL CLAY B Chief Executive Officer — 7,278 $20.48 $149,053
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
6.94
-23.23%
9.04
-35.50%
14.02
0.00
Operating Revenue
6.94
-23.23%
9.04
-35.50%
14.02
0.00
Operating Expense
231.05
+42.19%
162.50
+280.15%
42.75
+15.84%
36.90
Research And Development
187.29
+44.58%
129.54
+461.06%
23.09
-0.79%
23.27
Selling General And Administration
43.77
+32.81%
32.95
+67.65%
19.66
+44.23%
13.63
General And Administrative Expense
43.77
+32.81%
32.95
+67.65%
19.66
+44.23%
13.63
Other Gand A
43.77
+32.81%
32.95
+67.65%
19.66
+44.23%
13.63
Total Expenses
231.05
+42.19%
162.50
+280.15%
42.75
+15.84%
36.90
Operating Income
-224.11
-46.04%
-153.46
-434.17%
-28.73
+22.15%
-36.90
Total Operating Income As Reported
-224.11
+26.71%
-305.80
-179.19%
-109.53
-196.82%
-36.90
EBITDA
-221.16
-46.12%
-151.35
-440.55%
-28.00
+22.80%
-36.27
Normalized EBITDA
-221.16
-22439.19%
0.99
-98.13%
52.80
+245.58%
-36.27
Reconciled Depreciation
2.96
+40.58%
2.10
+188.74%
0.73
+15.37%
0.63
EBIT
-224.11
-46.04%
-153.46
-434.17%
-28.73
+22.15%
-36.90
Total Unusual Items
—
-152.34
-88.54%
-80.80
0.00
Total Unusual Items Excluding Goodwill
—
-152.34
-88.54%
-80.80
0.00
Special Income Charges
—
-152.34
-88.54%
-80.80
0.00
Other Special Charges
—
152.34
+88.54%
80.80
—
Restructuring And Mergern Acquisition
—
152.34
+88.54%
80.80
0.00
Net Income
-212.39
+27.50%
-292.96
-174.29%
-106.81
-189.48%
-36.90
Pretax Income
-212.39
+27.50%
-292.96
-174.29%
-106.81
-189.48%
-36.90
Net Non Operating Interest Income Expense
11.72
-8.71%
12.84
+371.26%
2.72
+54380.00%
0.01
Interest Expense Non Operating
—
—
—
—
Net Interest Income
11.72
-8.71%
12.84
+371.26%
2.72
+54380.00%
0.01
Interest Expense
—
—
—
—
Interest Income Non Operating
11.72
-8.71%
12.84
+371.26%
2.72
+54380.00%
0.01
Interest Income
11.72
-8.71%
12.84
+371.26%
2.72
+54380.00%
0.01
Other Income Expense
—
-152.34
-88.54%
-80.80
—
Other Non Operating Income Expenses
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-212.39
+27.50%
-292.96
-174.29%
-106.81
-189.48%
-36.90
Net Income From Continuing Operation Net Minority Interest
-212.39
+27.50%
-292.96
-174.29%
-106.81
-189.48%
-36.90
Net Income From Continuing And Discontinued Operation
-212.39
+27.50%
-292.96
-174.29%
-106.81
-189.48%
-36.90
Net Income Continuous Operations
-212.39
+27.50%
-292.96
-174.29%
-106.81
-189.48%
-36.90
Normalized Income
-212.39
-51.04%
-140.62
-440.76%
-26.00
+29.52%
-36.90
Net Income Common Stockholders
-212.39
+27.50%
-292.96
-174.29%
-106.81
-184.68%
-37.52
Otherunder Preferred Stock Dividend
—
—
0.00
-100.00%
0.62
Diluted EPS
-2.43
+51.40%
-5.00
+7.06%
-5.38
-74.11%
-3.09
Basic EPS
-2.43
+51.40%
-5.00
+7.06%
-5.38
-74.11%
-3.09
Basic Average Shares
87.35
+48.96%
58.64
+195.51%
19.84
+63.64%
12.13
Diluted Average Shares
87.35
+48.96%
58.64
+195.51%
19.84
+63.64%
12.13
Diluted NI Availto Com Stockholders
-212.39
+27.50%
-292.96
-174.29%
-106.81
-184.68%
-37.52
Total Other Finance Cost
—
—
—
-0.01
Line Item Trend 2023-12-31
Total Assets
148.54
Current Assets
144.70
Cash Cash Equivalents And Short Term Investments
138.14
Cash And Cash Equivalents
98.68
Other Short Term Investments
39.46
Receivables
0.29
Accounts Receivable
—
Other Receivables
—
Taxes Receivable
0.00
Accrued Interest Receivable
0.29
Prepaid Assets
2.00
Other Current Assets
6.56
Total Non Current Assets
3.84
Net PPE
3.64
Gross PPE
7.54
Accumulated Depreciation
-3.91
Properties
0.00
Buildings And Improvements
1.56
Machinery Furniture Equipment
0.36
Construction In Progress
0.00
Other Properties
5.39
Leases
0.23
Non Current Deferred Assets
0.00
Other Non Current Assets
0.20
Total Liabilities Net Minority Interest
28.66
Current Liabilities
21.83
Payables And Accrued Expenses
6.12
Payables
3.31
Accounts Payable
3.31
Current Accrued Expenses
2.81
Pensionand Other Post Retirement Benefit Plans Current
4.17
Current Debt And Capital Lease Obligation
0.31
Current Capital Lease Obligation
0.31
Current Deferred Liabilities
10.49
Current Deferred Revenue
10.49
Other Current Liabilities
0.73
Total Non Current Liabilities Net Minority Interest
6.83
Long Term Debt And Capital Lease Obligation
1.34
Long Term Capital Lease Obligation
1.34
Non Current Deferred Liabilities
5.49
Non Current Deferred Revenue
5.49
Other Non Current Liabilities
—
Stockholders Equity
119.88
Common Stock Equity
119.88
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
43.25
Ordinary Shares Number
43.25
Treasury Shares Number
0.00
Additional Paid In Capital
342.66
Retained Earnings
-222.81
Gains Losses Not Affecting Retained Earnings
0.02
Other Equity Adjustments
0.02
Total Equity Gross Minority Interest
119.88
Total Capitalization
119.88
Working Capital
122.87
Invested Capital
119.88
Total Debt
1.65
Capital Lease Obligations
1.65
Net Tangible Assets
119.88
Tangible Book Value
119.88
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-190.92
-72.32%
-110.79
-1363.98%
-7.57
+73.62%
-28.69
Cash Flow From Continuing Operating Activities
-190.92
-72.32%
-110.79
-1363.98%
-7.57
+73.62%
-28.69
Net Income From Continuing Operations
-212.39
+27.50%
-292.96
-174.29%
-106.81
-189.48%
-36.90
Depreciation Amortization Depletion
2.96
+40.58%
2.10
+188.74%
0.73
+15.37%
0.63
Depreciation
2.96
+40.58%
2.10
+188.74%
0.73
+15.37%
0.63
Depreciation And Amortization
2.96
+40.58%
2.10
+188.74%
0.73
+15.37%
0.63
Other Non Cash Items
10.00
-93.44%
152.34
+88.54%
80.80
—
Stock Based Compensation
25.69
+63.13%
15.75
+153.06%
6.22
+16.71%
5.33
Operating Gains Losses
0.90
—
—
—
Gain Loss On Sale Of PPE
0.90
0.00
—
—
Change In Working Capital
-15.23
-202.37%
14.87
+23.98%
12.00
+434.86%
2.24
Change In Prepaid Assets
-3.49
-485.10%
0.91
+121.86%
-4.14
-181.72%
5.07
Change In Payables And Accrued Expense
-4.63
-120.07%
23.08
+384500.00%
0.01
+100.23%
-2.60
Change In Accrued Expense
4.53
-66.55%
13.55
+2106.84%
0.61
+131.95%
-1.92
Change In Payable
-9.16
-196.20%
9.53
+1666.78%
-0.61
+10.19%
-0.68
Change In Account Payable
-9.16
-196.20%
9.53
+1666.78%
-0.61
+10.19%
-0.68
Change In Other Working Capital
-6.94
+23.23%
-9.04
-156.57%
15.98
—
Change In Other Current Liabilities
-0.17
-147.76%
-0.07
-143.79%
0.15
+166.81%
-0.23
Investing Cash Flow
60.80
+171.48%
-85.06
-179.04%
-30.48
-12191.94%
-0.25
Cash Flow From Continuing Investing Activities
60.80
+171.48%
-85.06
-179.04%
-30.48
-12191.94%
-0.25
Net PPE Purchase And Sale
-9.69
-35.02%
-7.17
-763.18%
-0.83
-235.08%
-0.25
Purchase Of PPE
-9.69
-35.02%
-7.17
-763.18%
-0.83
-235.08%
-0.25
Capital Expenditure
-15.93
+70.23%
-53.51
-6338.99%
-0.83
-235.08%
-0.25
Net Investment Purchase And Sale
76.73
+343.18%
-31.55
+18.94%
-38.93
0.00
Purchase Of Investment
-123.27
+33.93%
-186.56
-379.22%
-38.93
0.00
Sale Of Investment
200.00
+29.03%
155.00
0.00
—
Net Business Purchase And Sale
—
0.00
-100.00%
9.28
0.00
Net Intangibles Purchase And Sale
-6.25
+86.52%
-46.34
0.00
—
Purchase Of Intangibles
-6.25
+86.52%
-46.34
0.00
—
Financing Cash Flow
640.36
+166.23%
240.53
+106.63%
116.41
+363675.00%
0.03
Cash Flow From Continuing Financing Activities
640.36
+166.23%
240.53
+106.63%
116.41
+363675.00%
0.03
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
678.90
+171.56%
250.00
+99.95%
125.03
0.00
Proceeds From Stock Option Exercised
0.91
-84.14%
5.75
+1451.21%
0.37
+1059.38%
0.03
Net Other Financing Charges
-39.46
-159.10%
-15.23
-69.26%
-9.00
—
Changes In Cash
510.24
+1042.19%
44.67
-42.99%
78.36
+371.07%
-28.91
Beginning Cash Position
143.45
+45.22%
98.78
+383.67%
20.42
-58.60%
49.33
End Cash Position
653.69
+355.69%
143.45
+45.22%
98.78
+383.67%
20.42
Free Cash Flow
-206.85
-25.90%
-164.30
-1856.21%
-8.40
+70.98%
-28.94
Interest Paid Supplemental Data
—
—
—
0.00
Amortization Of Securities
-2.84
+2.07%
-2.90
-466.21%
-0.51
0.00
Common Stock Issuance
678.90
+171.56%
250.00
+99.95%
125.03
0.00
Issuance Of Capital Stock
678.90
+171.56%
250.00
+99.95%
125.03
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
Sale Of Business
—
0.00
-100.00%
9.28
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category